BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15610049)

  • 1. Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.
    Grier DG; Halliday HL
    Drugs; 2005; 65(1):15-29. PubMed ID: 15610049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
    Grier DG; Halliday HL
    Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Doyle LW
    Neonatology; 2021; 118(2):244-251. PubMed ID: 33975319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012-2019: a retrospective population cohort study.
    Yao S; Uthaya S; Gale C; Modi N; Battersby C;
    BMJ Open; 2022 Nov; 12(11):e063835. PubMed ID: 36396314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Filippone M; Nardo D; Bonadies L; Salvadori S; Baraldi E
    Am J Perinatol; 2019 Jul; 36(S 02):S58-S62. PubMed ID: 31238361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current strategies in the management of bronchopulmonary dysplasia: the role of corticosteroids.
    Knoppert DC; Mackanjee HR
    Neonatal Netw; 1994 Apr; 13(3):53-60. PubMed ID: 8152411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Concepts of Corticosteroids Use for the Prevention of Bronchopulmonary Dysplasia.
    Perrone S; Orlando S; Petrolini C; Marinelli F; Moretti S; Corradi M; Giordano M; De Bernardo G
    Curr Pediatr Rev; 2023; 19(3):276-284. PubMed ID: 36043724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001144. PubMed ID: 12535400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
    Doyle LW; Cheong JLY
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal corticosteroid response in neonates < 32 weeks and relation with placental pathology.
    Koenders VM; Appels A; van Straaten HLM; Dutman AC; Hemels MAC
    Eur J Pediatr; 2023 Jan; 182(1):265-274. PubMed ID: 36318297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits.
    Cheong JLY; Doyle LW
    Semin Fetal Neonatal Med; 2019 Jun; 24(3):197-201. PubMed ID: 30962159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. systemic corticosteroids.
    Szabó H; Baraldi E; Colin AA
    Pediatr Pulmonol; 2022 Mar; 57(3):600-608. PubMed ID: 34964559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
    Szabó H; Baraldi E; Colin AA
    Pediatr Pulmonol; 2022 Apr; 57(4):787-795. PubMed ID: 34964564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.